Tolerability, pharmacokinetics and pharmacodynamics of ascending single and repeated doses of SAR444336 in healthy adult participants

Trial Identifier:	TDU17072
Sponsor:	Sanofi
NCTID::	NCT05876767
Start Date:	October 2021
Study Completion Date:	February 2023
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Netherlands	Netherlands

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.